A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer (Q33900807)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer |
scientific article |
Statements
1 reference
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer (English)
1 reference
Charles Erlichman
1 reference
Cynthia X Ma
1 reference
Cesar Sanchez
1 reference
Feng Gao
1 reference
Robert Crowder
1 reference
Michael Naughton
1 reference
Timothy Pluard
1 reference
Allison Creekmore
1 reference
Zhanfang Guo
1 reference
Jeremy Hoog
1 reference
A Craig Lockhart
1 reference
Austin Doyle
1 reference
Matthew J Ellis
1 reference
18 January 2016
1 reference
1 reference
22
1 reference
11
1 reference
2650-2658
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference